300 related articles for article (PubMed ID: 24302004)
1. Suppression of the mTORC1/STAT3/Notch1 pathway by activated AMPK prevents hepatic insulin resistance induced by excess amino acids.
Li H; Lee J; He C; Zou MH; Xie Z
Am J Physiol Endocrinol Metab; 2014 Jan; 306(2):E197-209. PubMed ID: 24302004
[TBL] [Abstract][Full Text] [Related]
2. AMPK activation prevents excess nutrient-induced hepatic lipid accumulation by inhibiting mTORC1 signaling and endoplasmic reticulum stress response.
Li H; Min Q; Ouyang C; Lee J; He C; Zou MH; Xie Z
Biochim Biophys Acta; 2014 Sep; 1842(9):1844-54. PubMed ID: 25016145
[TBL] [Abstract][Full Text] [Related]
3. Signal transducer and activator of transcription 3 (STAT3) mediates amino acid inhibition of insulin signaling through serine 727 phosphorylation.
Kim JH; Yoon MS; Chen J
J Biol Chem; 2009 Dec; 284(51):35425-32. PubMed ID: 19875458
[TBL] [Abstract][Full Text] [Related]
4. The peroxisome proliferator-activated receptor (PPAR) β/δ agonist GW501516 inhibits IL-6-induced signal transducer and activator of transcription 3 (STAT3) activation and insulin resistance in human liver cells.
Serrano-Marco L; Barroso E; El Kochairi I; Palomer X; Michalik L; Wahli W; Vázquez-Carrera M
Diabetologia; 2012 Mar; 55(3):743-51. PubMed ID: 22179221
[TBL] [Abstract][Full Text] [Related]
5. Amino Acids Attenuate Insulin Action on Gluconeogenesis and Promote Fatty Acid Biosynthesis via mTORC1 Signaling Pathway in trout Hepatocytes.
Dai W; Panserat S; Plagnes-Juan E; Seiliez I; Skiba-Cassy S
Cell Physiol Biochem; 2015; 36(3):1084-100. PubMed ID: 26112996
[TBL] [Abstract][Full Text] [Related]
6. Ciclopirox olamine inhibits mTORC1 signaling by activation of AMPK.
Zhou H; Shang C; Wang M; Shen T; Kong L; Yu C; Ye Z; Luo Y; Liu L; Li Y; Huang S
Biochem Pharmacol; 2016 Sep; 116():39-50. PubMed ID: 27396756
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of Notch uncouples Akt activation from hepatic lipid accumulation by decreasing mTorc1 stability.
Pajvani UB; Qiang L; Kangsamaksin T; Kitajewski J; Ginsberg HN; Accili D
Nat Med; 2013 Aug; 19(8):1054-60. PubMed ID: 23832089
[TBL] [Abstract][Full Text] [Related]
8. Muscle mTORC1 suppression by IL-6 during cancer cachexia: a role for AMPK.
White JP; Puppa MJ; Gao S; Sato S; Welle SL; Carson JA
Am J Physiol Endocrinol Metab; 2013 May; 304(10):E1042-52. PubMed ID: 23531613
[TBL] [Abstract][Full Text] [Related]
9. Adenosine 5'-monophosphate-activated protein kinase regulates IL-10-mediated anti-inflammatory signaling pathways in macrophages.
Zhu YP; Brown JR; Sag D; Zhang L; Suttles J
J Immunol; 2015 Jan; 194(2):584-94. PubMed ID: 25512602
[TBL] [Abstract][Full Text] [Related]
10. Amino Acid-Induced Activation of mTORC1 in Rat Liver Is Attenuated by Short-Term Consumption of a High-Fat Diet.
Kimball SR; Ravi S; Gordon BS; Dennis MD; Jefferson LS
J Nutr; 2015 Nov; 145(11):2496-502. PubMed ID: 26400964
[TBL] [Abstract][Full Text] [Related]
11. AMPD1 regulates mTORC1-p70 S6 kinase axis in the control of insulin sensitivity in skeletal muscle.
Tandelilin AA; Hirase T; Hudoyo AW; Cheng J; Toyama K; Morisaki H; Morisaki T
BMC Endocr Disord; 2015 Mar; 15():11. PubMed ID: 25887856
[TBL] [Abstract][Full Text] [Related]
12. Differential contribution of insulin and amino acids to the mTORC1-autophagy pathway in the liver and muscle.
Naito T; Kuma A; Mizushima N
J Biol Chem; 2013 Jul; 288(29):21074-21081. PubMed ID: 23744068
[TBL] [Abstract][Full Text] [Related]
13. Dose-Dependent AMPK-Dependent and Independent Mechanisms of Berberine and Metformin Inhibition of mTORC1, ERK, DNA Synthesis and Proliferation in Pancreatic Cancer Cells.
Ming M; Sinnett-Smith J; Wang J; Soares HP; Young SH; Eibl G; Rozengurt E
PLoS One; 2014; 9(12):e114573. PubMed ID: 25493642
[TBL] [Abstract][Full Text] [Related]
14. Effects of sorafenib on energy metabolism in breast cancer cells: role of AMPK-mTORC1 signaling.
Fumarola C; Caffarra C; La Monica S; Galetti M; Alfieri RR; Cavazzoni A; Galvani E; Generali D; Petronini PG; Bonelli MA
Breast Cancer Res Treat; 2013 Aug; 141(1):67-78. PubMed ID: 23963659
[TBL] [Abstract][Full Text] [Related]
15. Smilax china L. Polyphenols Improves Insulin Resistance and Obesity in High-fat Diet-induced Mice Through IRS/AKT-AMPK and NF-κB Signaling Pathways.
Xu M; Xue H; Kong L; Lin L; Zheng G
Plant Foods Hum Nutr; 2023 Jun; 78(2):299-306. PubMed ID: 36826691
[TBL] [Abstract][Full Text] [Related]
16. Metformin Inhibits Hepatic mTORC1 Signaling via Dose-Dependent Mechanisms Involving AMPK and the TSC Complex.
Howell JJ; Hellberg K; Turner M; Talbott G; Kolar MJ; Ross DS; Hoxhaj G; Saghatelian A; Shaw RJ; Manning BD
Cell Metab; 2017 Feb; 25(2):463-471. PubMed ID: 28089566
[TBL] [Abstract][Full Text] [Related]
17. In vitro antiglioma action of indomethacin is mediated via AMP-activated protein kinase/mTOR complex 1 signalling pathway.
Pantovic A; Bosnjak M; Arsikin K; Kosic M; Mandic M; Ristic B; Tosic J; Grujicic D; Isakovic A; Micic N; Trajkovic V; Harhaji-Trajkovic L
Int J Biochem Cell Biol; 2017 Feb; 83():84-96. PubMed ID: 27988363
[TBL] [Abstract][Full Text] [Related]
18. Palmitate activates mTOR/p70S6K through AMPK inhibition and hypophosphorylation of raptor in skeletal muscle cells: Reversal by oleate is similar to metformin.
Kwon B; Querfurth HW
Biochimie; 2015 Nov; 118():141-50. PubMed ID: 26344902
[TBL] [Abstract][Full Text] [Related]
19. Uric acid-dependent inhibition of AMP kinase induces hepatic glucose production in diabetes and starvation: evolutionary implications of the uricase loss in hominids.
Cicerchi C; Li N; Kratzer J; Garcia G; Roncal-Jimenez CA; Tanabe K; Hunter B; Rivard CJ; Sautin YY; Gaucher EA; Johnson RJ; Lanaspa MA
FASEB J; 2014 Aug; 28(8):3339-50. PubMed ID: 24755741
[TBL] [Abstract][Full Text] [Related]
20. mTORC1 inhibition induces pain via IRS-1-dependent feedback activation of ERK.
Melemedjian OK; Khoutorsky A; Sorge RE; Yan J; Asiedu MN; Valdez A; Ghosh S; Dussor G; Mogil JS; Sonenberg N; Price TJ
Pain; 2013 Jul; 154(7):1080-91. PubMed ID: 23607966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
